MAPS Public Benefit
San Jose, US · Incorporated in Delaware
Founders & leadership
AE
Amy EmersonExecutive
BY
Berra Yazar-KlosinskiExecutive
MM
Michael MulletteExecutive
JG
Jeffery GeorgeNamed on SEC filing
AS
Andrew SeptimusNamed on SEC filing
BC
Blair Clark-SchoebNamed on SEC filing
DM
Dawn McColloughNamed on SEC filing
AN
Arman NadershahiNamed on SEC filing
SB
Suprotik BasuNamed on SEC filing
JP
Jason PyleNamed on SEC filing
GA
Gisselle AcevedoNamed on SEC filing
DG
Daniel GrossmanNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$215.1M disclosed across 1 round · 2023
▶$215.1MraisedSep 2023 · 62 investors · PharmaceuticalsRule 506(b)
▶$215.1MraisedSep 2023 · 62 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jeffery GeorgeDirector
- Amy EmersonExecutive Officer, Director
- Andrew SeptimusExecutive Officer
- Berra Yazar-KlosinskiExecutive Officer
- Michael MulletteExecutive Officer
- Blair Clark-SchoebExecutive Officer
- Dawn McColloughDirector
- Arman NadershahiExecutive Officer
- Suprotik BasuDirector
- Jason PyleDirector
- Gisselle AcevedoDirector
- Daniel GrossmanDirector
- Richard DoblinDirector
- James AcerExecutive Officer
- Amount sold
- $215.1M
- Finders' fees
- $547.5K
- Placement agents
- Big Path Capital LLC, Cowen and Company, LLC
- First sale
- Sep 2023
- Incorporated
- Other, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has MAPS Public Benefit raised?
- MAPS Public Benefit has disclosed $215.1M raised across 1 round.
- Where is MAPS Public Benefit headquartered?
- MAPS Public Benefit is headquartered in San Jose, US.